YKP1447, A Novel Potential Atypical Antipsychotic Agent |
Dong, Seon-Min
(Life Science Division, SK Holdings Co., Ltd.)
Kim, Yong-Gil (Life Science Division, SK Holdings Co., Ltd.) Heo, Joon (Life Science Division, SK Holdings Co., Ltd.) Ji, Mi-Kyung (Life Science Division, SK Holdings Co., Ltd.) Cho, Jeong-Woo (Life Science Division, SK Holdings Co., Ltd.) Kwak, Byong-Sung (Life Science Division, SK Holdings Co., Ltd.) |
1 | Meltzer HY, Li Z, Kaneda Y, Ichikawa J. Serotonin receptors: their key role in drugs to treat schizophrenia. Progr Neuro Psychopharmacol Biol Psychiatr 27: 1159−1172, 2003 DOI ScienceOn |
2 | Reavill C, Kettle A, Holland V, Riley G, Blackburn TP. Attenuation of haloperidol-induced catalepsy by a receptor antagonist. Br J Pharmacol 126: 572−574, 1999 DOI PUBMED ScienceOn |
3 | Seeman P, Van Tol HH. Dopamine receptor pharmacology. Trends Pharmacol Sci 15: 264−270, 1994 DOI PUBMED ScienceOn |
4 | Sibley DR, Monsma Jr FJ, Shen Y. Molecular neurobiology of dopaminergic receptors. Int Rev Neurobiol 35: 391−415, 1993 DOI PUBMED ScienceOn |
5 | Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor D3 as a target for neuroleptics. Nature 347: 146−151, 1990 DOI PUBMED ScienceOn |
6 | Sokoloff P, Schwartz JC. Novel dopamine receptors half a decade later. Trends Pharmacol Sci 16: 270−275, 1995 DOI PUBMED ScienceOn |
7 | Wadenberg ML, Hicks PB. The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics? Neurosci Biohav Rev 23: 851−862, 1999 DOI ScienceOn |
8 | Willins DL, Meltzer HY. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther 282: 699−706, 1997 ScienceOn |
9 | Aisa B, Tordera R, Lasheras B, Del Rio J, Ramirez MJ. Effects of maternal separation on hypothalamic-pituitary-adrenal responses, cognition and vulnerability to stress in adult female rats. Neuroscience 154: 1218−1226, 2008 DOI PUBMED ScienceOn |
10 | Bartoszyk GD, Amsterdam C van, Böttcher H, Seyfried CA. EMD 281014, a new selective serotonin 5-HT2A receptor antagonist. Eur J Pharmacol 473: 229−230, 2003 DOI PUBMED ScienceOn |
11 | Costentin J, Protais P, Schwartz JC. Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain. Nature 257: 405−407, 1975 DOI PUBMED ScienceOn |
12 | Davidson AB, Weidley E. Differential effects of neuroleptic and other psychotropic agents on acquisition of avoidance in rats. Life Sci 18: 1279−1284, 1976 DOI PUBMED ScienceOn |
13 | Egashira N, Mishima K, Uchida T, Hasebe N, Nagai H, Mizuki A, Iwasaki K, Ishii H, Nishimura RJ, Shoyama Y, Fujiwara M. Anandamide inhibits the DOI-induced head-twitch response in mice. Psychopharmacology 171: 382−389, 2004 DOI PUBMED ScienceOn |
14 | Stahl SM. Psychopharmacology of antidepressants. 1st ed. Martin Dunitz Ltd, London, p 31-38, 1997 |
15 | Snyder SH, Banergee SP, Yamamura HI, Greenberg D. Drugs, neurotransmitters and schizophrenia. Science 184: 1243−1245, 1974 DOI ScienceOn |
16 | Park WK, Jeong DY, Yun CW, Lee SH, Cho HY, Kim GD, Koh HY, Pae AN, Cho YS, Choi KI, Jung JY, Jung SH, Kong JY. Pharmacological actions of a novel and selective dopamine receptor antagonist, KCH-1110. Pharm Research 48: 615−622, 2003 DOI ScienceOn |
17 | Ogren SO, Hall H, Kohler C, Magnusson O, Lindbom LO, Angeby K, Florvall L. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain. Eur J Pharmacol 102: 459−474, 1984 DOI PUBMED ScienceOn |
18 | Darmani NA, Martin BR, Pandey U, Glennon RA. Do functional relationships exist between 5-HT1A and 5-HT2 receptors? Pharmacol Biochem Behav 36: 901−906, 1990 DOI ScienceOn |
19 | Janssen PAJ, Niemegeers CJE, Smellekens KHL. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data? Drug Res 15: 56−69, 1965 |
20 | Arnt J. Pharmacological specificity of conditioned avoidance response inhibition in rats. Inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta Pharmacol Toxicol 51: 321−329, 1982 DOI PUBMED ScienceOn |
21 | Protais P, Costentin J, Schwartz JC. Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psychopharmacology (Berlin) 50: 1−6, 1976 DOI ScienceOn |
22 | Carlsson A, Lindqvist M. Effect of chlorpromazine or haloperidol on the formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol (Kbh.) 20: 140−144, 1963 |
23 | Cook L, Morris RW, Mattis PA. Neuropharmacological and behavioral effects of chlorpromazine (thorazine hydrochloride). J Pharmacol Exp Ther 113: 11−12, 1955 |
24 | Protais P, Constentin J, Schwartz JC. Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psychopharmacology 50: 1−6, 1976 DOI PUBMED ScienceOn |
25 | Yoon BS, Park EH, Park EH, Kwon JT, Hong SB, Dong SM, Kim YH, Heo J, Ji MK, Kim YG, Kwak BS, Choi JS, Kim HT. Effects of a new antipsychotic drug (YKP1447) on impaired prepulse inhibition induced by apomorphine and phencyclidine in rats. Korean J Psychopharmacol 19: 38−45, 2008 |
26 | Wadenberg ML, Kapur S, Soliman A, Jones C. Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats. Psychopharmacology 150: 422−429, 2000 DOI PUBMED ScienceOn |
27 | Moore S, Kenyon P. Atypical antipsychotics, clozapine and sulpiride do not antagonize amphetamine-induced stereotyped locomotion. Psychopharmacology 114: 123−130, 1994 DOI PUBMED ScienceOn |
28 | Matthysse S. Antipsychotic drug actions: a clue to the pathology of schizophrenia? Fed Proc 32: 200−205, 1973 PUBMED ScienceOn |
29 | Moore NA, Tye NC, Axton MS, Risius FC. The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent. J Pharmacol Exp Ther 262: 545−551, 1992 |
30 | Gustafsson B, Christensson E. Amperozide, a new putative antipsychotic drug with a limbic mode of action on dopamine mediated behavior. Pharmacol Toxicol 66 Suppl 1: 12−17, 1990 DOI PUBMED ScienceOn |
31 | Peroutka SJ, Snyder SH. Relationship of neuroleptic drug effects at brain dopamine, serotonin, a-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 137: 1518−1522, 1980 DOI PUBMED |
32 | Jones BJ, Blackburn TP. The medical benefit of 5-HT research. Pharmacol Biochem Behav 71: 555−568, 2002 DOI ScienceOn |
33 | Van Rossum JM. The significance of dopamine-receptor blockade for the action of neuroleptic drugs. Arch Int Pharmacodyn Ther 160: 492−494, 1966 PUBMED |
34 | Dunham NW, Miya TS. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc 46: 208−209, 1957 |
35 | Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ. (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane)-induced head- twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors : modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J Pharmacol Exp Ther 273: 101−112, 1995 ScienceOn |
36 | Kroeze WK, Hufeisen SJ, Popadak BA, Renock SM, Steinberg S, Ernsberger P, Jayathilake K, Meltzer HY, Roth BL. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 28: 519−526, 2003 DOI PUBMED ScienceOn |